Cary Sanders, MD
Orthopaedic Surgery · Roseburg, ORNPI 1780782367
Payments from drug & device makers
Across 62 payments — averaging $121.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$4K
- Johnson & Johnson$1K
- Pacira Pharmaceuticals Incorporated$1K
- Stryker$794
- Medical Device Business Services, Inc.$59
- Smith+Nephew$41
- plus $112 from 6 others
What the payments were for
- Travel & lodging$5,64375%
- Food & beverage$1,90125%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 24 | $4,371 |
| Johnson & Johnson | 11 | $1,149 |
| Pacira Pharmaceuticals Incorporated | 7 | $1,019 |
| Stryker | 10 | $794 |
| Medical Device Business Services, Inc. | 2 | $59 |
| Smith+Nephew | 2 | $41 |
| DJO, LLC | 1 | $28 |
| Sanara Medtech Inc. | 1 | $20 |
| Zimmer Biomet | 1 | $18 |
| Bioventus LLC | 1 | $16 |
| Solventum Corporation | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GMK SPHERE$2,819
- Iovera$883
- GLOBAL$821
- DELTA$821
- TRUMATCH$821
- AMIStem H Femoral Stems$699
- MAKO$460
- GMK Sphere Revision System$253
- LCP$213
- T2$109
- AXSOS$109
- VARIAX$109
- VA-LCP$107
- NA$107
- Fibulink$107
How this compares
$7,544 in reported general payments places this provider in the 70th percentile of 228 orthopaedic surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 52 | $1,710 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 123 | $1,104 |
| Meloxicam | 102 | $594 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $336 |
| Ondansetron OdtOndansetron | 11 | $195 |
| Mupirocin | 27 | $178 |
| Clindamycin Hcl | 21 | $71 |
| Amoxicillin | 38 | $45 |
| Tramadol Hcl | 14 | $32 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Roseburg
- Patrick DenardMedford$14.1M
- James BallardOregon City$2.8M
- Steven MadeyLake Oswego$1.2M
- Daniel FitzpatrickEugene$629K
- Paul DuweliusPortland$622K
- Jonathan SalesPortland$529K
- Elizabeth LiebermanPortland$383K
- Michelle WelbornPortland$364K
- Rudolf HoellrichEugene$323K
- Daniel RobertsonLincoln City$294K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.